Celine Michaut-Simon

Title: Celine Michaut-Simon: Innovator in Cognitive Dysfunction Treatment

Introduction

Celine Michaut-Simon is a notable inventor based in Illkirch, France. She has made significant contributions to the field of cognitive dysfunction treatment through her innovative research and development of therapeutic compounds.

Latest Patents

Celine holds a patent for "Substituted-N-heteroaryl compounds and uses thereof." This patent focuses on activators of Kv3.1 and/or Kv3.2 channels, which are therapeutically useful in treating cognitive dysfunction and the negative symptoms associated with central nervous system disorders. These disorders include schizophrenia, Alzheimer's disease, Tourette's syndrome, autism, dementia, epilepsy, and other conditions where gamma oscillations are dysfunctional. The activators she developed include substituted N-heteroaryl compounds.

Career Highlights

Celine is currently associated with Bionomics Inc., where she continues her research and development efforts. Her work has been instrumental in advancing therapeutic options for patients suffering from various cognitive disorders.

Collaborations

Celine collaborates with talented professionals in her field, including Hamish Toop and Dharam Paul. Their combined expertise contributes to the innovative projects at Bionomics Inc.

Conclusion

Celine Michaut-Simon is a pioneering inventor whose work in developing therapeutic compounds has the potential to significantly impact the treatment of cognitive dysfunction. Her contributions to the field are invaluable and highlight the importance of innovation in addressing complex health challenges.